171 related articles for article (PubMed ID: 17505146)
1. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy.
Kase S; Yokoi M; Saito W; Furudate N; Ohgami K; Kitamura M; Kitaichi N; Yoshida K; Kase M; Ohno S; Uede T
Ophthalmic Res; 2007; 39(3):143-7. PubMed ID: 17505146
[TBL] [Abstract][Full Text] [Related]
2. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis.
Hasegawa M; Nakoshi Y; Iino T; Sudo A; Segawa T; Maeda M; Yoshida T; Uchida A
J Rheumatol; 2009 Feb; 36(2):240-5. PubMed ID: 19208558
[TBL] [Abstract][Full Text] [Related]
4. Decreased vitreal hyaluronan levels with aging.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
[TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
Er H; Doğanay S; Ozerol E; Yürekli M
Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
[TBL] [Abstract][Full Text] [Related]
6. Vitreous leptin levels in retinal disease.
Maberley D; Cui JZ; Matsubara JA
Eye (Lond); 2006 Jul; 20(7):801-4. PubMed ID: 16052255
[TBL] [Abstract][Full Text] [Related]
7. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
8. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.
Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F
Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415
[TBL] [Abstract][Full Text] [Related]
9. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
10. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
11. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.
Yoneda S; Hara H; Hirata A; Fukushima M; Inomata Y; Tanihara H
Jpn J Ophthalmol; 2005; 49(2):106-8. PubMed ID: 15838725
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of monokine induced by interferon-gamma (Mig) in the vitreous of patients with diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Takeuchi M; Kezuka T; Iwasaki T; Goto H
Diabet Med; 2008 Jul; 25(7):875-7. PubMed ID: 18644076
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
14. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
[TBL] [Abstract][Full Text] [Related]
17. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases.
Kocak N; Alacacioglu I; Kaynak S; Ozcan MA; Celik O; Yuksel F; Piskin O; Oner H; Saatci AO; Ergin M
Ann Ophthalmol (Skokie); 2010; 42 Spec No():10-4. PubMed ID: 21138144
[TBL] [Abstract][Full Text] [Related]
18. Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy.
Hara H; Oh-hashi K; Yoneda S; Shimazawa M; Inatani M; Tanihara H; Kiuchi K
Mol Vis; 2006 Aug; 12():977-82. PubMed ID: 16943769
[TBL] [Abstract][Full Text] [Related]
19. Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis.
Cho S; Ahn YS; Choi YS; Seo SK; Nam A; Kim HY; Kim JH; Park KH; Cho DJ; Lee BS
Am J Reprod Immunol; 2009 Apr; 61(4):286-93. PubMed ID: 19260859
[TBL] [Abstract][Full Text] [Related]
20. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
